VINORELBINE AN vinorelbine (as tartrate) 10 mg/1 mL concentrated injection vial

País: Australia

Idioma: inglés

Fuente: Department of Health (Therapeutic Goods Administration)

Ingredientes activos:

vinorelbine tartrate, Quantity: 13.85 mg (Equivalent: vinorelbine, Qty 10 mg)

Disponible desde:

Amneal Pharma Australia Pty Ltd

Designación común internacional (DCI):

Vinorelbine tartrate

formulario farmacéutico:

Injection, concentrated

Composición:

Excipient Ingredients: water for injections

Vía de administración:

Intravenous Infusion

Unidades en paquete:

Pack of 1 x 1 mL vial, Pack of 10 x 1 mL vials, Pack of 5 x 1 mL vials

tipo de receta:

(S4) Prescription Only Medicine

indicaciones terapéuticas:

Treatment of advanced breast cancer after failure of standard therapy, as a single agent or in combination; and as a first line treatment for advanced non-small cell lung cancer, as a single agent or in combination.

Resumen del producto:

Visual Identification: Clear solution; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 2 Years; Container Temperature: Store at 2 to 8 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Estado de Autorización:

Licence status A

Fecha de autorización:

2012-01-18